Adgyl Lifesciences Private Limited - Company Profile

It is a pharma foreign private limited company based in Bengaluru, Karnataka, India, established in 2018.
2018 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Adgyl Lifesciences Private Limited

Adgyl Lifesciences Private Limited, a active foreign private limited company, was established on 27 November 2018 in Bengaluru, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74999KA2018FTC118861. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹16.00 Cr and a paid-up capital of ₹13.21 Cr.

It upholds a compliant status. Employing 241 professional, Its leadership includes Haladasappa Krishnappa (Managing Director), Suresh Kumar (Additional Director), Girish Suhas Joshi (Additional Director). Past directors included Haladasappa Krishnappa, Amith Gurpur Yeshwanth, Neeraj Rameshwar Garg. It holds ₹5.67 M open charges and ₹3.03 M settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 21 & 22, Phase Ii, Peenya Industrial Area,, Bengaluru, Karnataka, 560058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999KA2018FTC118861

  • Registration Number

    118861

  • Incorporation Date

    27 November 2018

  • Authorized Capital

    ₹16.00 Cr

  • Paid-Up Capital

    ₹13.21 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 16.00 Cr
  • Paid Up Capital ₹ 13.21 Cr
  • Company Age 7 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.67 M
  • Satisfied Charges ₹ 3.03 M
  • Revenue Growth **** 63.30%
  • Profit Growth **** 41.38%
  • Ebitda **** 55.61%
  • Net Worth 9.52%
  • Total Assets **** 18.66%
Company report

Adgyl Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Adgyl Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Adgyl Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Haladasappa Krishnappa Managing Director 11 Jul 2023 Current
Suresh Kumar Additional Director 17 Dec 2025 Current
Girish Suhas Joshi Additional Director 03 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 11 Jul 2023 Past
Pramod Abcsdd Director 25 Apr 2019 Past
Pramod Abcsdd Additional Director 30 Aug 2019 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 31 Dec 2024 Past
Pramod Abcsdd Additional Director 25 Feb 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Adgyl Lifesciences.

Adgyl Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.3% increase. The company also saw a substantial improvement in profitability, with a 41.38% increase in profit. The company's net worth moved up by a moderate rise of 9.52%.

Adgyl Lifesciences revenue growth over time
Adgyl Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 63.30%
*******
*******
*******
*******
Revenue from Operations
*******
 59.36%
*******
*******
*******
*******
Total Assets
*******
 18.66%
*******
*******
*******
*******
Profit or Loss
*******
 41.38%
*******
*******
*******
*******
Net Worth
*******
 9.52%
*******
*******
*******
*******
EBITDA
*******
 55.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Adgyl Lifesciences?

In 2023, Adgyl Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,670,149.00

Satisfied Charges

₹3,034,583.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 0.57 Cr
Latest Charge Details
Date Lender Amount Status
27 Mar 2024 Axis Bank Limited ₹5.67 M Open
31 Oct 2023 Axis Bank Limited ₹3.03 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Adgyl Lifesciences?

Adgyl Lifesciences has a workforce of 241 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Adgyl Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adgyl Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Adgyl Lifesciences
Recent Activity within the Organization
  • Charges

    A charge registered on 31 Oct 2023 via Charge ID 100810690 with Axis Bank Limited was fully satisfied on 26 Dec 2025. was recorded as a recent event.

  • Director Appointment

    The activity Suresh Kumar was appointed as a Additional Director was appointed as a Additional Director on 17 Dec 2025 & has been associated with this company since 2 months 20 days . was completed.

  • Annual General Meeting

    Adgyl Lifesciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Girish Suhas Joshi was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2025 & has been associated with this company since 6 months 3 days . was documented.

  • Balance Sheet

    The activity Adgyl Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 0.57 Cr with Charge ID 100899518 was registered on 27 Mar 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Adgyl Lifesciences Private Limited?

The CIN of Adgyl Lifesciences Private Limited is U74999KA2018FTC118861.

Where is Adgyl Lifesciences Private Limited headquartered?

Adgyl Lifesciences Private Limited is headquartered at 21 & 22, Phase Ii, Peenya Industrial Area,, Bengaluru, Karnataka, 560058.

When was Adgyl Lifesciences Private Limited incorporated?

Adgyl Lifesciences Private Limited was incorporated on 27 November 2018.

Who are the current directors of Adgyl Lifesciences Private Limited?

The current directors of Adgyl Lifesciences Private Limited are

What is the primary industry of Adgyl Lifesciences Private Limited?

The primary industry of Adgyl Lifesciences Private Limited is Professional, Scientific And Technical.

Is Adgyl Lifesciences Private Limited a listed company?

Adgyl Lifesciences Private Limited is unlisted.

What is the capital structure of Adgyl Lifesciences Private Limited?

The authorized capital of Adgyl Lifesciences Private Limited is ₹16.00 Cr, and the paid-up capital is ₹13.21 Cr.

What is the compliance status of Adgyl Lifesciences Private Limited?

The compliance status of Adgyl Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available